XML 28 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (As Restated [Member], USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 24, 2012
Jun. 26, 2011
As Restated [Member]
   
Operating activities    
Net income, including redeemable noncontrolling interests $ 33,768 $ 30,095
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for uncollectible accounts and notes receivable 719 (7)
Depreciation and amortization 16,031 16,737
Deferred income taxes 1,797 4,022
Stock-based compensation expense 3,218 3,903
Excess tax benefit on equity awards (1,471) (403)
Other 2,872 1,133
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (75) (1,167)
Inventories 533 1,819
Prepaid expenses (338) (268)
Other current assets 755 22
Other assets and liabilities 756 1,219
Accounts payable (587) (1,970)
Income and other taxes payable 75 325
Accrued expenses and other current liabilities 3,297 (1,611)
Deferred revenue 3,812 (924)
Net cash provided by operating activities 65,162 52,925
Investing activities    
Purchases of property and equipment (15,046) (12,422)
Loans issued (1,206) (1,684)
Repayments of loans issued 1,730 3,920
Acquisitions, net of cash acquired (5,908)  
Proceeds from divestitures of restaurants 948  
Other (4) 51
Net cash used in investing activities (19,486) (10,135)
Financing activities    
Net repayments on line of credit facility (1,489) (51,000)
Excess tax benefit on equity awards 1,471 403
Tax payments for restricted stock issuances (822) (798)
Proceeds from exercise of stock options 10,400 10,663
Acquisition of Company common stock (38,728) (26,162)
Distributions to redeemable noncontrolling interest holders (1,930) (2,029)
Other 125 42
Net cash used in financing activities (30,973) (68,881)
Effect of exchange rate changes on cash and cash equivalents (20) 82
Change in cash and cash equivalents 14,683 (26,009)
Cash and cash equivalents at beginning of period 18,942 47,829
Cash and cash equivalents at end of period $ 33,625 $ 21,820